Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1207 |
Name of the vaccine | CJCV1 |
Microbe | Bacteria |
Disease name | Campylobacteriosis |
Name of bacteria | Campylobacter genus |
Type of vaccine | Conjugate |
Nucleic acid content | Circular DNA |
Age | 18 to 50 years |
Description of the vaccine | Capsule-conjugate Campylobacter vaccine. |
Name of the manufacturer | U.S. Army Medical Research and Development Command |
Name of the manufacturing country | United States |
Year of manufacture | 2016 |
Clinical Phase status | Clinical - Phase 1 |
Bacterial strain | Gram-negative bacteria. |
Efficacy | NA |
Vaccine formulation | Lyophilized |
Dosage | Three doses. |
Mechanism of action | Serum immunological response (both IgA and IgG) against the CPS moiety. |
Route of administration | Intramuscular |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | With or without Alhydrogel |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | NA |
PubMed identifier | 30252591 |
Clinical trial number | NCT02067676 |
Reference | NA |
Other name | NA |
Additional Links | NA |